Brief: Klaria Pharma Publishes Summary Of External Valuation
16/10/2026 07:34
BRIEF-Klaria Pharma Publishes Summary Of External Valuation Oct 16 (Reuters) - Klaria Pharma Holding AB (publ) KLAR.ST:
EXTERNAL VALUATION ESTIMATES PEAK SALES FOR SUMATRIPTAN ALGINATE FILM AT ABOUT USD 500 MILLION PER YEAR
EXPECTS MILESTONE PAYMENTS AND ROYALTIES FOR FIRST EUROPEAN MARKETS
CNX AND KLARIA TARGET 10-30% MARKET SHARE IN EUROPEAN SUMATRIPTAN MARKET
Source text: ID:nWkr3X0XFF
Further company coverage: KLAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement